Bridgewater, N.J.-based Clinical Genomics launched Colvera, a blood-based test for colorectal cancer recurrence monitoring. Here’s what you need to know. 1. Colvera is a qualitative test that ...

ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, Inc., a clinical-stage company bridging the precision medicine gap by decoding RNA, announced today the validation and launch of OncoPrism ®-NSCLC, an ...

With three new partnerships, 10x Genomics signals a move beyond research tools toward clinical diagnostics using its single-cell and spatial biology platforms.

REVEAL GENOMICS, S.L. is a Barcelona-based biotechnology company that discovers, develops, and markets innovative diagnostic ...

ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, Inc., a clinical-stage company bridging the precision medicine gap by decoding RNA, announced the publication of their PREDAPT clinical trial ...

Providing patient-centered education and navigation support significantly increases consent rates for genomic testing, making ...

FORT MYERS, Fla. and FREMONT, Calif., April 29, 2025 /PRNewswire/ -- NeoGenomics, Inc. (NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, and Ultima Genomics, ...

The market is rapidly transitioning from episodic diagnostics to continuous health monitoring. By 2035, the integration of ...

The Alzheimer's Association released its first comprehensive clinical practice guidelines for the diagnosis, treatment, and care of Alzheimer's disease (AD) at the end of July. This landmark document ...

The UC Santa Cruz Colligan Clinical Diagnostic Laboratory (CCDL) has received its CLIA certificate of registration from the California Department of Public Health, which clears the way for it to begin ...